A Study of LY2140023 in Healthy Males and Females

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The study will evaluate the effect of different particle size of LY2140023. The study involves 4 single doses of 80 milligrams (mg) LY2140023 taken as 1 tablet by mouth with a washout period of at least 3 days between doses. This study will last approximately 60 days not including screening. Screening is required within 30 days prior to study entry.
Epistemonikos ID: 049f8f4717e78c51e1bf5e5daa8d35a42827d3d4
First added on: May 10, 2024